These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9862373)

  • 1. Thymus-dependent monoclonal antibody-induced protection from transferred diabetes.
    Parish NM; Bowie L; Zusman Harach S; Phillips JM; Cooke A
    Eur J Immunol; 1998 Dec; 28(12):4362-73. PubMed ID: 9862373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerance to IDDM induced by CD4 antibodies in nonobese diabetic mice is reversed by cyclophosphamide.
    Parish NM; Hutchings PR; Waldmann H; Cooke A
    Diabetes; 1993 Nov; 42(11):1601-5. PubMed ID: 8405701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterisation of CD8 monoclonal antibody-induced protection from diabetes in NOD mice.
    Parish N; Cooke A
    Autoimmunity; 2005 Dec; 38(8):597-604. PubMed ID: 16390812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between alphabetaTCR+CD4-CD8- T-cell deficiency and IDDM in NOD/Lt mice.
    Baxter AG; Kinder SJ; Hammond KJ; Scollay R; Godfrey DI
    Diabetes; 1997 Apr; 46(4):572-82. PubMed ID: 9075796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nondepleting anti-CD4 monoclonal antibody prevents diabetes and blocks induction of insulin autoantibodies following insulin peptide B:9-23 immunization in the NOD mouse.
    Liu E; Moriyama H; Paronen J; Abiru N; Miao D; Yu L; Taylor RM; Eisenbarth GS
    J Autoimmun; 2003 Nov; 21(3):213-9. PubMed ID: 14599846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The thymus as a site for evaluating the potency of candidate beta cell autoantigens in NOD mice.
    Gerling IC; Atkinson MA; Leiter EH
    J Autoimmun; 1994 Dec; 7(6):851-8. PubMed ID: 7888041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NOD fetal thymus organ culture: an in vitro model for the development of T cells involved in IDDM.
    Wilson SS; DeLuca D
    J Autoimmun; 1997 Oct; 10(5):461-72. PubMed ID: 9376074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence of CD4+ regulatory T cells in the non-obese diabetic male mouse.
    Sempé P; Richard MF; Bach JF; Boitard C
    Diabetologia; 1994 Apr; 37(4):337-43. PubMed ID: 7914880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term in vivo depletion of functional CD4+ T lymphocytes from calves requires both thymectomy and anti-CD4 monoclonal antibody treatment.
    Valdez RA; McGuire TC; Brown WC; Davis WC; Knowles DP
    Immunology; 2001 Apr; 102(4):426-33. PubMed ID: 11328376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor-alpha regulation of CD4+CD25+ T cell levels in NOD mice.
    Wu AJ; Hua H; Munson SH; McDevitt HO
    Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12287-92. PubMed ID: 12221281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The regulation of autoimmunity through CD4+ T cells.
    Hutchings P; Parish N; O'Reilly L; Dawe K; Roitt IM; Cooke A
    Autoimmunity; 1993; 15 Suppl():21-3. PubMed ID: 8105991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of bone marrow and thymus chimerism between non-obese diabetic (NOD) and NOD-E transgenic mice, on the expression and prevention of diabetes.
    Parish NM; Chandler P; Quartey-Papafio R; Simpson E; Cooke A
    Eur J Immunol; 1993 Oct; 23(10):2667-75. PubMed ID: 8405065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function.
    Cameron MJ; Arreaza GA; Zucker P; Chensue SW; Strieter RM; Chakrabarti S; Delovitch TL
    J Immunol; 1997 Nov; 159(10):4686-92. PubMed ID: 9366391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine- and costimulation-mediated therapy of IDDM.
    Cameron MJ; Arreaza GA; Delovitch TL
    Crit Rev Immunol; 1997; 17(5-6):537-44. PubMed ID: 9419441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of diabetes but not insulitis in NOD mice injected with antibody to CD4.
    Hayward AR; Shriber M; Cooke A; Waldmann H
    J Autoimmun; 1993 Jun; 6(3):301-10. PubMed ID: 8104407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mature mainstream TCR alpha beta+CD4+ thymocytes expressing L-selectin mediate "active tolerance" in the nonobese diabetic mouse.
    Herbelin A; Gombert JM; Lepault F; Bach JF; Chatenoud L
    J Immunol; 1998 Sep; 161(5):2620-8. PubMed ID: 9725264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of tolerance in murine autoimmune diabetes by transient blockade of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 pathway.
    Moriyama H; Yokono K; Amano K; Nagata M; Hasegawa Y; Okamoto N; Tsukamoto K; Miki M; Yoneda R; Yagi N; Tominaga Y; Kikutani H; Hioki K; Okumura K; Yagita H; Kasuga M
    J Immunol; 1996 Oct; 157(8):3737-43. PubMed ID: 8871677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4+CD8- thymocytes that express L-selectin protect rats from diabetes upon adoptive transfer.
    Seddon B; Saoudi A; Nicholson M; Mason D
    Eur J Immunol; 1996 Nov; 26(11):2702-8. PubMed ID: 8921958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell repopulation following neonatal injection of non-obese diabetic (NOD) mice with anti-T-cell antibodies.
    Hayward A; Shriber M; Kubo R; McDuffie M
    Immunology; 1992 May; 76(1):110-6. PubMed ID: 1385796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD3 antibody treatment stimulates the functional capability of regulatory T cells.
    Chatenoud L
    Novartis Found Symp; 2003; 252():279-86; discussion 286-90. PubMed ID: 14609225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.